260 related articles for article (PubMed ID: 9751609)
1. Constitutive and antibody-induced internalization of prostate-specific membrane antigen.
Liu H; Rajasekaran AK; Moy P; Xia Y; Kim S; Navarro V; Rahmati R; Bander NH
Cancer Res; 1998 Sep; 58(18):4055-60. PubMed ID: 9751609
[TBL] [Abstract][Full Text] [Related]
2. Analysis of glycosylation of prostate-specific membrane antigen derived from LNCaP cells, prostatic carcinoma tumors, and serum from prostate cancer patients.
Holmes EH; Greene TG; Tino WT; Boynton AL; Aldape HC; Misrock SL; Murphy GP
Prostate Suppl; 1996; 7():25-9. PubMed ID: 8950359
[TBL] [Abstract][Full Text] [Related]
3. Saporin toxin-conjugated monoclonal antibody targeting prostate-specific membrane antigen has potent anticancer activity.
Kuroda K; Liu H; Kim S; Guo M; Navarro V; Bander NH
Prostate; 2010 Sep; 70(12):1286-94. PubMed ID: 20623630
[TBL] [Abstract][Full Text] [Related]
4. Targeting epitopes in prostate-specific membrane antigen for antibody therapy of prostate cancer.
Kinoshita Y; Kuratsukuri K; Newman N; Rovito PM; Kaumaya PT; Wang CY; Haas GP
Prostate Cancer Prostatic Dis; 2005; 8(4):359-63. PubMed ID: 16172607
[TBL] [Abstract][Full Text] [Related]
5. Measurement of prostate-specific membrane antigen in the serum with a new antibody.
Murphy GP; Tino WT; Holmes EH; Boynton AL; Erickson SJ; Bowes VA; Barren RJ; Tjoa BA; Misrock SL; Ragde H; Kenny GM
Prostate; 1996 Apr; 28(4):266-71. PubMed ID: 8602402
[TBL] [Abstract][Full Text] [Related]
6. Prostate-specific membrane antigen and its truncated form PSM'.
Mlcochová P; Barinka C; Tykvart J; Sácha P; Konvalinka J
Prostate; 2009 Apr; 69(5):471-9. PubMed ID: 19107881
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium.
Liu H; Moy P; Kim S; Xia Y; Rajasekaran A; Navarro V; Knudsen B; Bander NH
Cancer Res; 1997 Sep; 57(17):3629-34. PubMed ID: 9288760
[TBL] [Abstract][Full Text] [Related]
8. Targeting and cellular trafficking of magnetic nanoparticles for prostate cancer imaging.
Serda RE; Adolphi NL; Bisoffi M; Sillerud LO
Mol Imaging; 2007; 6(4):277-88. PubMed ID: 17711783
[TBL] [Abstract][Full Text] [Related]
9. Purification of prostate-specific membrane antigen using conformational epitope-specific antibody-affinity chromatography.
Liu T; Toriyabe Y; Berkman CE
Protein Expr Purif; 2006 Oct; 49(2):251-5. PubMed ID: 16815035
[TBL] [Abstract][Full Text] [Related]
10. 1alpha,25-Dihydroxyvitamin D3 down-regulates expression of prostate specific membrane antigen in prostate cancer cells.
Serda RE; Bisoffi M; Thompson TA; Ji M; Omdahl JL; Sillerud LO
Prostate; 2008 May; 68(7):773-83. PubMed ID: 18247401
[TBL] [Abstract][Full Text] [Related]
11. Expression of prostate specific membrane antigen in androgen-independent prostate cancer cell line PC-3.
Laidler P; Dulińska J; Lekka M; Lekki J
Arch Biochem Biophys; 2005 Mar; 435(1):1-14. PubMed ID: 15680901
[TBL] [Abstract][Full Text] [Related]
12. In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen.
Smith-Jones PM; Vallabahajosula S; Goldsmith SJ; Navarro V; Hunter CJ; Bastidas D; Bander NH
Cancer Res; 2000 Sep; 60(18):5237-43. PubMed ID: 11016653
[TBL] [Abstract][Full Text] [Related]
13. Target-dependent T-cell activation by coligation with a PSMA x CD3 diabody induces lysis of prostate cancer cells.
Bühler P; Molnar E; Dopfer EP; Wolf P; Gierschner D; Wetterauer U; Schamel WW; Elsässer-Beile U
J Immunother; 2009; 32(6):565-73. PubMed ID: 19483653
[TBL] [Abstract][Full Text] [Related]
14. A new generation of monoclonal and recombinant antibodies against cell-adherent prostate specific membrane antigen for diagnostic and therapeutic targeting of prostate cancer.
Elsässer-Beile U; Wolf P; Gierschner D; Bühler P; Schultze-Seemann W; Wetterauer U
Prostate; 2006 Sep; 66(13):1359-70. PubMed ID: 16894535
[TBL] [Abstract][Full Text] [Related]
15. Location of prostate-specific membrane antigen in the LNCaP prostate carcinoma cell line.
Troyer JK; Beckett ML; Wright GL
Prostate; 1997 Mar; 30(4):232-42. PubMed ID: 9111600
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro testing of J591 antibody-dendrimer conjugates for targeted prostate cancer therapy.
Patri AK; Myc A; Beals J; Thomas TP; Bander NH; Baker JR
Bioconjug Chem; 2004; 15(6):1174-81. PubMed ID: 15546182
[TBL] [Abstract][Full Text] [Related]
17. Discriminatory Role of Detergent-Resistant Membranes in the Dimerization and Endocytosis of Prostate-Specific Membrane Antigen.
Schmidt S; Gericke B; Fracasso G; Ramarli D; Colombatti M; Naim HY
PLoS One; 2013; 8(6):e66193. PubMed ID: 23840421
[TBL] [Abstract][Full Text] [Related]
18. Biorecognition and subcellular trafficking of HPMA copolymer-anti-PSMA antibody conjugates by prostate cancer cells.
Liu J; Kopecková P; Bühler P; Wolf P; Pan H; Bauer H; Elsässer-Beile U; Kopecek J
Mol Pharm; 2009; 6(3):959-70. PubMed ID: 19344119
[TBL] [Abstract][Full Text] [Related]
19. [Correlation study of expression levels of prostate-specific membrane antigen and prostate-specific antigen with Gleason score of prostate carcinoma].
Ren JQ; Chen ZQ; Zheng L; Chen Q; Li H; Zhu HG
Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):735-8. PubMed ID: 15733392
[TBL] [Abstract][Full Text] [Related]
20. Cell-Surface labeling and internalization by a fluorescent inhibitor of prostate-specific membrane antigen.
Liu T; Wu LY; Kazak M; Berkman CE
Prostate; 2008 Jun; 68(9):955-64. PubMed ID: 18361407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
